Joseph Podojil, PHD

Dr. Joseph Podojil is an experienced investigator with a keen interest in the expression and function of the novel immune modulatory proteins and mechanisms. Dr. Podojil has extensive experience with the analysis of T cell and B cell responses both in vivo and in in vitro. During his graduate school training, Dr. Podojil’s work focused on the ability of neurotransmitters released from the sympathetic nervous system to modulate B cell function/antibody production during an immune response. During Dr. Podojil’s postdoctoral training, his primary research focus was to determine the cellular and molecular mechanisms underlying the differential effect of costimulatory and co-inhibitory molecules expressed by T cells to modulate immune cell function in disease models of multiple sclerosis, type-1 diabetes, and cancer.

Dr. Podojil has published manuscripts in top tier scientific journals including Nature, Nature Neuroscience, Nature Communications, Nature Reviews Immunology, the Journal of Biological Chemistry, and the Journal of Immunology. Dr. Podojil holds a B.S. in Molecular Biology from Benedictine University, and Ph.D. in Cell Biology, Neurobiology, and Anatomy from Loyola University Chicago Medical School. He has also trained at the Ohio State University and Northwestern University. Dr. Podojil has ten years of experience consulting with a number of biotechnology and pharmaceutical companies, having assisted in the development of new therapeutics from proof of concept through to Phase 1 clinical testing.